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INTRODUCTION
Class 1 P-glycoproteins (Pgps) are ATP-dependent drug transporting membrane proteins, typically associated with multidrug resistance in cancer therapy 1, 2 . In humans, the drug transporting Pgp is encoded by the MDR1 gene 3 , whereas in rodents two drug transporting Pgp isoforms have been identified, encoded by the Mdr1a and Mdr1b genes, respectively 4, 5 . The closely related human MDR3 and rodent Mdr2 proteins do not confer multidrug resistance, but primarily function as phosphatidylcholine flippases 6 . Class 1 Pgps confer drug resistance to cells by the active excretion of a variety of structurally unrelated hydrophobic natural product drugs, e.g. vinca alkaloids and anthracyclines, which ultimately results in reduced cytoplasmic drug concentrations and drug-induced toxicity 1, 2 . Tissue distribution studies revealed that class 1 Pgps are not only expressed in drug resistant cells, but also in the apical domain of cells in normal tissue with excretory functions, such as liver (canalicular membrane of hepatocytes), small intestine (brush border membrane of enterocytes), kidney (brush border membrane of proximal tubule cells), and at the blood-brain barrier (capillary endothelial cells) 7 . Considering the distribution pattern in excretory organs, combined with their capacity to transport drugs, it has been suggested that in mammals class 1 Pgps are involved in the excretion and disposition of amphiphilic substrates. First evidence in support of this hypothesis was obtained by Kamimoto et al. 8 . In studies with rat liver canalicular membrane vesicles they demonstrated that class 1 Pgps may be involved in the hepatobiliary excretion of various drugs. Later studies, in which other substrates or other techniques were employed further supported these observations 9, 10 . In the study of Müller et al. 10 ,
preliminary evidence was obtained indicating ATP-dependent transport of the cationic drugs N-(4',4'-azo-n-pentyl)-

21-deoxyajmalinium and N-(n-pentyl)-quinidine
into rat canalicular plasma membrane vesicles was mediated by Mdr1 Pgps. However, stereoselective aspects of this transport were not studied. More recently, experiments with Mdr1 gene knockout mice have shed light on the importance of class 1 Pgps in vivo. Mice with a disruption of the Mdr1 genes grow and develop normally, are fertile, and have no obvious abnormality under laboratory conditions. However, these mice are very sensitive to mdr-related toxic chemicals, including chemotherapeutic drugs, due to profoundly reduced clearance of these agents in liver, intestine, and brain 11 . Interestingly, absence of class 1 Pgps results in a significant reduction in excretion rates not only of typical Pgp substrates, like natural product drugs, but also of aliphatic organic cations 12, 13 , suggesting that class 1 Pgps are also involved in the elimination of relatively small, permanently-charged cationic drugs. Results from a recent in vitro study, in which transfected polarized cells were used, support these observations 14 . However, it should be noted that in the before-mentioned studies Pgpmediated drug transport can only indirectly inferred. Furthermore, potential influences of the knockout or transfection procedures on transport proteins, other than the Pgps, can not be entirely excluded in these studies. In order to provide direct information on Pgp-mediated transport of relatively small, permanently-charged cationic drugs, we have performed uptake studies with membrane vesicle preparations isolated from Pgp-overexpressing cells using quaternary derivatives of the enantiomers quinidine and quinine as model substrates. Specifically, we have investigated whether these cationic drugs are substrates for human MDR1-, rat Mdr1b-, or rat Mdr2-Pgp, and compared the observed kinetic parameters using vincristine transport as a reference. Moreover, by evaluating the transport of two diastereomers we were able to address possible stereoselectivity of class 1 Pgp-mediated transport. 15 . Unlabeled N-methylquinidine and N-methylquinine were also obtained by N-methylation of quinidine and quinine, respectively. The molecular weight of the model compounds was assessed by mass spectroscopy, confirming the methylation of the quinuclidine nitrogen 15 . Radiochemical purity of the not commercially available substrates was determined by thin-layer chromatography and exceeded 99%. ATP, creatine phosphate, and creatine kinase were purchased from Boehringer Mannheim GmbH (Mannheim, Germany). Vincristine, β,γ-methyleneadenosine 5'-triphosphate (AMP-PCP) were obtained from Sigma Chemical Co. (St. Louis, MO). All other chemicals were of analytical grade and readily available from commercial sources. The Bac-to-Bac baculovirus expression system was obtained from Life Technologies (Breda, The Netherlands). Sf21 insect cells were purchased from Invitrogen (Leek, The Netherlands) and cultured in Insect Xpress medium (BioWhittaker, Walkersville, MD) supplemented with 5% fetal bovine serum and 25 µg ml -1 penicillin, 25 µg ml -1 streptomycin and 50 µg ml -1 neomycin (Life Technologies). A mouse monoclonal antibody C219 (Signet Laboratories Inc, Dedham, MA) was used for detection of P-glycoproteins. Cellulose acetate filters (OE66) were from Schleicher & Schuell (Dassel, Germany), and glass microfibre filters (GF/F) were purchased from Whatman (Maidstone, UK). Molecular biology reagents were obtained from Promega Corporation (Leiden, The Netherlands) or Boehringer Mannheim. Plasmids containing the rat Mdr1b cDNA 16 or rat Mdr2 cDNA 17 were generously provided by Dr JA Silverman, (AvMax Inc., Berkeley, USA) whereas Dr US Rao (University of North Carolina, Chapel Hill, USA) kindly provided an aliquot of a high titer baculovirus stock containing the human MDR1 gene 18 .
EXPERIMENTAL PROCEDURES MATERIALS
PRODUCTION OF RECOMBINANT BACULOVIRUS AND VIRAL INFECTION
Recombinant baculoviruses were generated using the Bac-to-Bac baculovirus expression system from Life Technologies, according to the manufacturer's instructions. Briefly, the rat Mdr1b coding sequence, a 4.3 kb EcoRI fragment obtained after digestion of pGEM11-Mdr1b, was ligated in the EcoRI site of pFASTBAC1, whereas the rat Mdr2 coding sequence, a 3.9 kb XbaI fragment obtained after digestion of pGEM7-Mdr2, was ligated in the XbaI site of pFASTBAC1. Clones with the correct orientation of the Mdr1b or Mdr2 cDNA in pFASTBAC1 were identified by restriction analysis with XbaI or SacI, respectively, and confirmed by DNA sequencing. Recombinant bacmids were created and used for transfection of Sf21 insect cells using Cellfectin reagent. After 5 days culture medium was collected and used for a plaque assay. Single plaques were isolated, eluted into medium and used for 3-rounds of amplification to obtain high titer virus stocks. The resulting virus stocks had a titer of 5-8 10 7 pfu ml -1 , as determined by plaque assays, and were used for the production of recombinant protein in Sf21 insect cells. The baculovirus stock containing the human MDR1 gene, donated by Dr U.S. Rao, was amplified to obtain large volumes of a high titer virus stock. Sf21 insect cells were infected at a multiplicity of infection of 2-4 with recombinant baculoviruses. For control experiments, Sf21 insect cells were infected with recombinant baculoviruses containing the β-glucuronidase gene (Life Technologies). Plasma membrane fractions were isolated 65-67 hours after infection (see below).
ISOLATION OF PLASMA MEMBRANE FRACTIONS
Plasma membrane-enriched fractions were isolated from infected Sf21 insect cells by sucrose gradient centrifugation techniques according to Müller et al. 19 with some modifications. Briefly, cells were harvested, washed with phosphate buffered saline (PBS), mM: NaCl 137, KCl 2.7, Na 2 HPO 4 10.1, KH 2 PO 4 1.8, pH (7.4 ) and centrifuged at 700 g for 10 min at 4 °C. The resulting pellet was diluted 50 fold in hypotonic buffer (0.5 mM sodium phosphate) supplemented with 0.1 mM EDTA and 0.1 mM phenylmethylsulfonyl fluoride (PMSF) and stirred gently for 90 min on ice. The cell lysate was centrifuged at 100,000 g for 45 min at 4 °C. The pellet of the crude membranes was resuspended in isotonic TS buffer (10 mM Tris-HCl, pH 7.4, 250 mM sucrose) supplemented with 0.1 mM EDTA and 0.1 mM PMSF, and homogenized with a Dounce B homogenizer (50 strokes up-and-down). The suspension was layered on top of a 38% (w/w) sucrose solution and centrifuged at 280,000 g for 2 hrs at 4 °C in a swing out rotor. The interface layer was collected, diluted to 25 ml in TS buffer and centrifuged at 100,000 g for 45 min at 4 °C. The resulting pellet was resuspended in isotonic buffer. Vesicles were formed by passing the suspension 25 times through a 25 gauge needle. The membrane vesicles were snap frozen in liquid nitrogen and stored at -80 °C until further use.
IMMUNOBLOT BLOT ANALYSIS AND QUANTIFICATION OF MDR1 AND MDR1B P-GLYCOPROTEINS IN
MEMBRANES
Plasma membrane-enriched protein fractions were separated by sodium dodecyl sulfatepolyacrylamide (final concentration 7.5%) gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose (Amersham International, Buckinghamshire, UK) using a tankblotting system according to manufacturer's instructions (BioRad Laboratories, Hercules, CA). BDH molecular weight standards (42, ,000 Dalton range, BDH Ltd, Dorset, UK) were used as marker proteins. The blots were stained with Ponceau S-solution (0.1% Ponceau S (w/v) in 5% acetic acid (v/v), Sigma) to confirm equal transfer of proteins. The blots were incubated with the monoclonal antibody C219 (dilution 1:2,000) in PBS containing 4% non-fat dried milk powder (Fluka BioChemica, Buchs, Switzerland) and 0.05% polyoxyethylene sorbitan monolaurate (Tween-20, Sigma), washed in PBS / 0.05 % Tween-20, subsequently incubated with horse-radish peroxidase labeled rabbit anti-mouse IgG (dilution 1:2,000, DAKO A/S, Glostrup, Denmark) and finally developed using Pierce SuperSignal Chemiluminescent Substrate Luminol/Enhancer (Pierce, Rockford, IL). The amount of MDR1 or Mdr1b in membrane fractions was determined by quantitative immunoblotting. Briefly, samples were serially diluted in TS buffer. Standard solutions of purified human MDR1 or rat Mdr1b P-glycoprotein with known protein concentration were prepared by electroelution (see below). Samples and standards, containing 350 ng to 25 ng of P-glycoprotein, were separated by SDS-PAGE, transferred to nitrocellulose and stained with C219. Band intensities of the immunoblots were quantified using ImageMaster 1D Elite software, version 3.0 (Pharmacia, Uppsala, Sweden).
ELECTROELUTION OF MDR1 AND MDR1B
Plasma membrane-enriched protein fractions were separated by SDS-PAGE. After electrophoresis, the positions of MDR1 and Mdr1b were determined by staining of the gel in 0.3 M CuCl 2 20 . The horizontal strips containing P-glycoproteins were cut out, destained in 250 mM EDTA/250 mM Tris HCl (pH 9.0), minced, and placed into the glass tubes of a BioRad 422 Electro-Eluter Module (BioRad Laboratories). Elution was carried out at 10 mA per tube at constant current for 5 h in 20 mM Tris/150 mM glycine buffer (pH 8.3) containing 0.01% (w/v) SDS, with membrane caps with a cut-off of 12-15 kDa. After elution, protein concentrations of purified samples were determined by densitometric analysis of Coomassie-stained polyacrylamide gels, using BSA as a standard. Images of gels were taken using a charge-coupled device video camera of the ImageMaster VDS system (Pharmacia) and band intensities were quantified using ImageMaster software (Pharmacia).
TRANSPORT STUDIES WITH MEMBRANE VESICLES
Transport of [ 3 H]-labeled substrates was measured by a rapid filtration technique using cellulose acetate (0.20 µm pore size, Schleicher & Schuell) or glass microfibre filters (0.70 µm pore size, Whatman), according to Renes et al. 21 with some slight modifications. Briefly, membrane vesicles were rapidly thawed and then preincubated at 37 °C in the presence of 4 mM ATP, 10 mM MgCl 2 , 10 mM creatine phosphate, 100 µg ml -1 of creatine kinase, 250 mM sucrose, 10 mM Tris HCl (pH 7.4). After 1 min the labeled substrate was added (final volume 40 µl). At the indicated time points 1 ml of ice-cold stop solution (PBS) was added to the membranes. This solution was subsequently filtered through cellulose acetate filters (for N-methylquinidine and N-methylquinine) or glass microfibre filters (for vincristine), that were presoaked in PBS. Filters were rinsed with 5 ml PBS/ 1% BSA, followed by 5 ml PBS/0.05% Tween-20 and 5 ml PBS. After rinsing, the filters were air dried, dissolved, and radioactivity was measured in a liquid scintillation counter. In control experiments ATP was replaced by 4 mM AMP-PCP. Net ATP-dependent transport was calculated by subtracting values obtained in the presence of AMP-PCP from those obtained in the presence of ATP.
PARTITION COEFFICIENT DETERMINATIONS
The relative hydrophilicity of the cationic compounds was analyzed by determining the octanolaqueous phase partitioning coefficients (P) from an n-octanol and isotonic TS buffer system. Briefly, radiolabeled compounds were dissolved in equal volumes of n-octanol and TS buffer. The two phases were mixed continuously for 2 hours at 20 °C. The layers were separated by centrifugation at 2500 RPM for 15 min, and analyzed in a liquid scintillation counter.
ANALYTICAL PROCEDURES
Protein concentrations of membrane preparations were determined with the DC Protein Assay from BioRad Laboratories (Hercules, CA) using BSA as standard. Kinetic uptake parameters were determined by nonlinear curve fitting to an equation describing simple Michaelis-Menten enzyme
, using SigmaPlot 3.03 (Jandel Scientific Corporation, San Rafael, CA).
STATISTICAL ANALYSIS
All data are presented as mean values ± SEM, unless otherwise stated. Statistical analysis between the experimental groups in the inhibition study was performed using one-way analysis of variance (ANOVA), followed by the Student-Newman-Keuls test. Levels of significance for statistical analysis was set at P<0.05. Expression of MDR1, Mdr1b, and Mdr2 in isolated membrane preparations from infected Sf21 insect cells was examined by immunoblot analysis using the monoclonal antibody C219. For comparison, membranes from A2780AD cells, a MDR1-overexpressing multidrug resistant human ovarian cell line 21 were included in the immunoblot analysis. Human MDR1 was detected in membrane preparations isolated from insect cells infected with a MDR1-expressing recombinant baculovirus (Sf-MDR1 membranes), and in membranes prepared from A2780AD cells (Figure 1 ). The apparent molecular weight of MDR1 expressed in insect cells is smaller than MDR1 detected in A2780AD cells, which can be attributed to differences in post-translational modifications 22,23. Furthermore, the expression level of human MDR1 in Sf21 cells is approximately 4 times higher than in A2780AD cells. In addition, strong C219-immunoreactive signals were observed in membrane preparations from Sf21 cells infected with either rat Mdr1b-or Mdr2-expressing recombinant baculoviruses (Sf-Mdr1b and Sf-Mdr2 membranes, respectively). No C219-immunoreactive signals were observed in non-infected Sf21 insect cells. The amount of MDR1 or Mdr1b present in membrane preparations was determined by quantitative immunoblotting using the monoclonal antibody C219. This antibody recognizes conserved epitopes close to the ATP binding cassette present in all known members of the Pgp-subfamily 24 . However, the peptide epitopes in human MDR1 and rat Mdr1b bind to C219 antibody with different affinities [data not shown, Georges et al. 24 ]. Thus, it is not possible to directly determine and compare Pgp expression levels solely by immunoblot analysis of equal amounts of Sf-MDR1 and Sf-Mdr1b membrane preparations loaded on the same gel. Pgp contents of membrane preparations were therefore determined by immunoblotting using purified MDR1 or Mdr1b as standards.
ATP-DEPENDENT UPTAKE OF CATIONIC DRUGS IN MEMBRANE VESICLES FROM MDR1-, MDR1B-AND MDR2-OVEREXPRESSING INSECT CELLS.
In this study we used the monoquaternary quinidine and quinine derivatives Nmethylquinidine and N-methylquinine as cationic model compounds 15 , whereas the transport properties of vincristine, a classic class 1 Pgp substrate 1, 21 , were used as a reference. The relative lipophilicity values of the substrates, expressed as log P values, were 0.31 ± 0.04, 0.11 ± 0.02, and 1.92 ± 0.03 (n=4) for N-methylquinidine, N-methylquinine, and vincristine, respectively. At the beginning of our experiments we evaluated whether the three P-glycoproteins were able to transport the permanently charged cations. Figure 2A 
Membrane vesicles were isolated from MDR1-, Mdr1b-, or Mdr2-overexpressing, or non-infected insect cells. At the time points indicated, transport of radiolabeled substrates into Sf-MDR1 (closed circles), Sf-Mdr1b (open triangles), Sf-Mdr2 (closed squares), or Sf21 (open diamonds) membrane vesicles (25-30 µg of protein) was determined as described in Experimental Procedures. Uptake was determined for [ 3 H]-N-methylquinidine (panel A), and [ 3 H]-N-methylquinine (panel B), each at a final concentration of 200 nM. The uptake experiments presented in panel A and B were performed under identical conditions, i.e. on the same day with the same membrane vesicle preparations and reaction buffers. ATP-dependent uptake was calculated by subtracting values obtained in the presence of 4 mM AMP-PCP from those obtained in the presence of 4 mM ATP. Data points represent the mean ± standard deviation of triplicate determinations of a typical experiment.
To confirm that vesicle-associated increase of radioactivity reflects transport of the substrate into a vesicular space rather than nonspecific binding to membranes, the medium osmolarity dependence of 8 µM [ 3 H]-N-methylquinidine uptake into Sf-MDR1 and Sf-Mdr1b membrane vesicles was studied. By increasing the extravesicular sucrose concentration from 250 mM (isotonic condition) to 850 mM, the intravesicular volume decreases due to the osmolarity-mediated shrinkage of the vesicles, resulting in decreased uptake. As shown in Figure 3 , initial rates of [ 3 H]-N-methylquinidine uptake in Sf-MDR1 and Sf-Mdr1b membrane vesicles decreased linearly with increasing concentrations of sucrose. This demonstrates that increased vesicle-associated radioactivity is due to ATPdependent uptake of the cationic substrate. The data presented in Figure 2A and 2B suggest that N-methylquinidine is a better substrate than N-methylquinine for both MDR1 and Mdr1b. This may imply that MDR1 and Mdr1b display stereoselectivity. We therefore determined the apparent MichaelisMenten constants, K m , and the maximal initial uptake rates, V max , for the uptake of these enantiomers into Sf-MDR1 and Sf-Mdr1b membrane vesicles. For comparison we also determined the kinetic constants for the uptake of vincristine for both P-glycoproteins. For these experiments an uptake period of 15, 25, and 50 sec was chosen to approximate initial rates of transport for vincristine, N-methylquinidine, and N-methylquinine, respectively. Since one of the aims of this study was to compare the kinetic properties of MDR1 and Mdr1b, the initial rates of transport were normalized to Pgp content of vesicle preparations and are expressed in pmol substrate·min -1 ·µg Pgp -1 . MDR1-and Mdr1b-mediated initial uptake rates of substrates were saturable and are depicted in Figure 4 ; the kinetic constants for the uptake are summarized in Table 1 . The apparent K m constants for ATP-dependent uptake of N-methylquinidine and N-methylquinine by MDR1 were similar, whereas the K m constant for Mdr1b-mediated uptake of N-methylquinine was about two-times higher than that of N-methylquinidine. For MDR1, as well as for Mdr1b, we observed that the V max constants for the uptake of N-methylquinine were considerably [ 
M). Transport of [ 3 H]-Nmethylquinidine was determined as described in Experimental Procedures. ATP-dependent uptake was calculated by subtracting values obtained in the presence of 4 mM AMP-PCP from those obtained in the presence of 4 mM ATP. Data points represent the mean ± standard deviation of triplicate determinations.
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smaller than those for N-methylquinidine uptake. The uptake of vincristine by Sf-MDR1 or Sf-Mdr1b vesicles was half-saturated at almost equal concentrations, whereas the maximal initial velocity of uptake of vincristine by MDR1 exceeded that of Mdr1b. Based on these data we conclude that N-methylquinidine is a better substrate for MDR1 and Mdr1b than N-methylquinine. In addition, our data suggest that human MDR1 has a higher transport activity than its rat orthologue Mdr1b.
INHIBITION OF [3H]-N-METHYLQUINIDINE TRANSPORT MEDIATED BY MDR1 AND MDR1B
ATP-dependent [ 3 H]-N-methylquinidine transport into Sf-MDR1 and Sf-Mdr1b membrane vesicles was measured in the presence of various potential competing substrates and inhibitors (Table 2) . PSC-833, a non-immunosuppressive analogue of cyclosporin A and a potent inhibitor of Pgps 25 , profoundly inhibited the ATP-dependent uptake of 8 µM [ 3 H]-N-methylquinidine into both Sf-MDR1 and Sf-Mdr1b membrane vesicles. An increasing concentration of unlabeled N-methylquinidine decreased the uptake of radiolabeled substrate up to almost 100%. Its diastereomer N-methylquinine also inhibited uptake of radiolabeled substrate into membrane vesicles, although less pronounced than N-methylquinidine. A similar tendency was observed for the nonmethylated, weakly basic drugs quinidine and quinine. At equal concentrations quinidine was a better inhibitor of [ 3 H]-N-methylquinidine transport than the diastereomer quinine. Uptake of [ 3 H]-N-methylquinidine into Sf-MDR1 and Sf-Mdr1b membrane vesicles was also inhibited by the vinca alkaloid vincristine, whereas the anthracycline daunorubicin only affected the uptake of N-methylquinidine at relatively high concentrations.
DISCUSSION
Substrates for class 1 Pgps differ in their chemical structure and physicochemical properties 2 . Many substrates contain basic tertiary amine groups that may be protonated, depending on their pK a value and the pH of the solution, and are therefore distinct from 
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Mdr1b permanently charged cations. In this study we have examined whether the permanently charged methylated derivatives of the enantiomers quinidine and quinine are substrates for human MDR1, rat Mdr1b, and rat Mdr2. Compared with non-or mock-infected cells, membrane vesicles prepared from MDR1-or Mdr1b-overexpressing cells clearly showed ATP-dependent transport of these substrates. Class 1 Pgp-mediated ATP-dependent transport of the cationic substrates into membrane vesicles was saturable, occurred into an osmotically sensitive space, and could be dose-dependently inhibited by unlabelled substrate, the Pgp-inhibitor PSC-833, and various other drugs including the classic Pgp substrates vincristine and daunorubicin. In contrast, no Mdr2-mediated transport of the tested substrates was observed. This is in accordance with the restricted substrate specificity of Mdr2 and its human orthologue MDR3 6, 26 . Taken together, the present studies unequivocally identify the diastereomers N-methylquinidine and N-methylquinine as substrates for MDR1 and Mdr1b, but not for Mdr2. MDR1 and Mdr1b display stereospecificity for the translocation of the two diastereomers, as is indicated by the remarkable differences in the observed V max constants, and the differential inhibition of N-methylquinidine uptake by two pairs of stereoisomers. Our data demonstrate that N-methylquinidine is a better substrate for both MDR1 and Mdr1b than N-methylquinine. Stereoselectivity for MDR1 has been noted previously: based on the capacity of various agents to reverse resistance in Pgp-overexpressing mdr cell lines, the (R)-diastereomer quinidine has been recognized as a more potent inhibitor of Pgp than the (S)-diastereomer quinine 27, 28 . Stereoselective inhibition of MDR1 has also been reported for the diastereomers of propranolol 29 , cinchonidine 28 , and flupentixol 30, 31 . It is remarkable that MDR1 and Mdr1b, known as transporters that functionally interact with many unrelated compounds, differentially transport stereoisomers that display (relatively) small spatial differences. Presently, a definite molecular explanation for this stereoselectivity can not be given. The wide variety of data on the potential mechanisms of class 1 Pgp-mediated transport indicates at least two transport modalities (discussed in more detail below): class 1 Pgps may extract amphiphatic substrates from the membrane releasing it into the extracellular aqueous phase. Alternatively, class 1 Pgps may operate as a 'pump', translocating substrates across the membrane directly from the cytosol into the extracellular fluid. In the current study we directly assayed the MDR1-and Mdr1b-mediated transport of Nmethylquinidine and N-methylquinine. Therefore, our data on stereoselective transport of these two diastereomers demonstrate that a three-dimensional structure of the supposed drug interaction domain(s) of MDR1 and Mdr1b seems of importance for vectorial Pgpmediated transport. This notion is based on the following observations: Figure 2A and 2B show that under identical conditions, i.e. equal concentrations of substrates and MDR1 or Mdr1b, the initial uptake of N-methylquinidine is greater than of N-methylquinine for both MDR1 and Mdr1b. In contrast to the marked differences between the normalized V max constants for the MDR1-and Mdr1b-mediated uptake of the enantiomers, we found that the apparent K m constants differ only slightly. This indicates that the differences in handling of the isomers by MDR1 and Mdr1b are due to variations in substrate handling at a point subsequent to the initial binding interaction. Moreover, this may imply that post-binding dissociation events, but not binding itself, represents the rate limiting step in Pgp-mediated transport of these enantiomers. Interestingly, chirality is not only of interest in relation to either substrates or competitive inhibitors of Pgp, but also for Pgp-inhibitors that are not transported by Pgp 2 . The latter category of agents likely acts as noncompetitive inhibitors that bind either to the drug interaction site(s) or to modulator binding sites 2, 32 . By comparing the interactions of the cis-and trans-isomers of flupentixol with wild-type or mutant (F983A) MDR1, Dey et al. 33 recently provided evidence that the tricyclic core of both isomers are recognized by a common site of MDR1. The stereospecific features of these enantiomers rather result from interactions of the piperazinyl side chain with distinct regions of MDR1 near the recognition site, that are influenced by its spatial orientation 33 . Furthermore, since flupentixol itself is not transported by MDR1, and transport of several anti-neoplastic drugs was not influenced by the above mentioned mutation, these authors concluded that the phenylalanine residue at position 983 is not part of the substrate binding site, but rather is part of the modulatory site for flupentixol. This study provides further evidence that allosteric interactions may play a role in MDR1-mediated transport 2 .
In the present study we also demonstrated that human MDR1 has a higher transport activity than its rat orthologue Mdr1b, as indicated by the distinctions between the normalized V max constants. Despite their high level of sequence similarity (80% at amino acid level), this is not unexpected. It has been shown that the two murine drug transporting isoforms, Mdr1a and Mdr1b, display overlapping, but distinct drug resistance phenotypes 34 , and transport [ 3 H]-vinblastine with different efficiency 35 , in spite of their equal affinity and binding capacity towards this substrate 36 . Moreover, as summarized by Ambudkar et al. 2 , studies with mutated Pgps revealed that a change of only one amino acid may already dramatically affect the initial rate of drug uptake in accumulation assays with transfected cells. Nevertheless, we would like to emphasize that the finding that human MDR1 is more effective in transporting drugs than rat Mdr1b may be of pharmacological significance. In the process of drug development, the in vivo analysis of drug disposition and elimination usually relies on studies with laboratory animals. Also, the potential role of Pgp in clinically significant drug-drug interactions is currently not fully recognized 37 . The observed functional differences between human MDR1 and rat Mdr1b may enable the extrapolation to humans of pharmacokinetic data obtained in rats, resulting into a higher predictive value with regard to elimination and bioavailability of Pgp substrates in humans. In addition, our data may provide further clues for possible drug-drug interactions at the level of Pgp. Presently, the molecular mechanism by which class 1 Pgps perform their transport function is still a subject of debate. Class 1 Pgps may both reduce the influx rate of drugs into the cytoplasm, and increase the efflux out of multidrug resistant cells 1, 38 . It has been hypothesized that class 1 Pgps recognize and remove hydrophobic drugs directly from the lipid bilayer, for example in a process comparable to the action of a hydrophobic vacuum cleaner 39 . Another version of this model suggests that class 1 Pgps act as flippases 40 that translocate drugs from the inner leaflet to the outer leaflet of the membrane, where it would passively equilibrate with the aqueous medium. Stein 41 proposes that substrates are moved into a 'medium-accessible' cavity, formed by the class 1 Pgp molecule, before they are released into the external medium. Interestingly, an opposite working model is presented by Altenberg et al. 42 . These authors speculate that class 1 Pgps operate as an efflux pump, transporting substrates directly from the cytosol into the extracellular medium. In the current study we show that N-methylquinidine is an excellent substrate for both MDR1 and Mdr1b, with a transport capacity that comes close to that of the much more hydrophobic drug vincristine. In view of the marked differences in log P values it is unlikely that N-methylquinidine and N-methylquinine will partition into the lipid phase of membranes to the same extent as vincristine. In this respect, the presently studied N-alkylated derivatives of quinidine and quinine, that have a permanently positively-charged (quaternary) nitrogen center, may behave fundamentally different from the tertiary parent compounds. The latter are able to diffuse into, and to cross membranes in the non-charged lipophilic form. Consequently, our observations do not fit well in the mentioned models that assume class 1 Pgps extract its substrate from the lipid bilayer. Our data are more comparable with models that postulate substrates are removed directly from the cytosol. Yet, this leaves open the possibility that the monoquaternary cations studied can enter a putative 'active site' from the lipid bilayer.
In conclusion, we have demonstrated that permanently positively-charged derivatives of the diastereomers quinidine and quinine are transported by human MDR1 and rat Mdr1b, but not by rat Mdr2. Moreover, the (R)-diastereomer N-methylquinidine is a better substrate for both MDR1 and Mdr1b than the (S)-diastereomer N-methylquinine. Finally, human MDR1 is more effective in transporting drugs than its rat orthologue Mdr1b.
